Renaissance Technologies’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-162,184
| Closed | -$2.4M | – | 4117 |
|
|
2024
Q1 | $2.4M | Buy |
162,184
+113,284
| +232% | +$1.67M | ﹤0.01% | 1911 |
|
|
2023
Q4 | $656K | Buy |
+48,900
| New | +$656K | ﹤0.01% | 2649 |
|
|
2022
Q1 | – | Sell |
-19,461
| Closed | -$76K | – | 4667 |
|
|
2021
Q4 | $76K | Sell |
19,461
-43,059
| -69% | -$168K | ﹤0.01% | 3730 |
|
|
2021
Q3 | $302K | Sell |
62,520
-39,450
| -39% | -$191K | ﹤0.01% | 3082 |
|
|
2021
Q2 | $652K | Sell |
101,970
-86,191
| -46% | -$551K | ﹤0.01% | 2858 |
|
|
2021
Q1 | $1.18M | Buy |
188,161
+11,300
| +6% | +$71K | ﹤0.01% | 2540 |
|
|
2020
Q4 | $1.22M | Buy |
+176,861
| New | +$1.22M | ﹤0.01% | 2402 |
|
|
2020
Q1 | – | Sell |
-33,961
| Closed | -$107K | – | 4027 |
|
|
2019
Q4 | $107K | Buy |
+33,961
| New | +$107K | ﹤0.01% | 3309 |
|
|
2018
Q2 | – | Sell |
-294,997
| Closed | -$1.87M | – | 3722 |
|
|
2018
Q1 | $1.87M | Buy |
+294,997
| New | +$1.87M | ﹤0.01% | 2358 |
|
|
2016
Q3 | – | Sell |
-94,666
| Closed | -$4.02M | – | 3605 |
|
|
2016
Q2 | $4.02M | Buy |
94,666
+13,752
| +17% | +$583K | 0.01% | 1752 |
|
|
2016
Q1 | $5.33M | Buy |
+80,914
| New | +$5.33M | 0.01% | 1574 |
|
|
2015
Q3 | – | Sell |
-2,175
| Closed | -$212K | – | 3506 |
|
|
2015
Q2 | $212K | Buy |
+2,175
| New | +$212K | ﹤0.01% | 2970 |
|
|
2015
Q1 | – | Sell |
-32,463
| Closed | -$2.89M | – | 3458 |
|
|
2014
Q4 | $2.89M | Sell |
32,463
-8,363
| -20% | -$743K | 0.01% | 1593 |
|
|
2014
Q3 | $2.82M | Sell |
40,826
-31,546
| -44% | -$2.18M | 0.01% | 1483 |
|
|
2014
Q2 | $4.15M | Buy |
+72,372
| New | +$4.15M | 0.01% | 1333 |
|